Technical Analysis for ONCR - Oncorus, Inc.

Grade Last Price % Change Price Change
F 13.72 2.01% 0.27
ONCR closed down 5.01 percent on Monday, April 12, 2021, on 65 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Flat
Historical ONCR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 2.01%
Boomer Sell Setup Bearish Swing Setup -3.11%
Narrow Range Bar Range Contraction -3.11%
NR7 Range Contraction -3.11%
NR7-2 Range Contraction -3.11%
Inside Day Range Contraction -3.11%
Wide Bands Range Expansion -3.11%
NR7 Range Contraction -3.72%
Inside Day Range Contraction -3.72%
Wide Bands Range Expansion -3.72%
Older End-of-Day Signals for ONCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 3 hours ago
Rose Above Previous Day's High about 5 hours ago
Rose Above 10 DMA about 5 hours ago
20 DMA Resistance about 5 hours ago
Up 5% about 5 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Oncorus, Inc., a clinical stage biopharmaceutical company, focuses to develop viral immunotherapies for cancer patients. Its lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform that it is in Phase I clinical trial to treat various cancers. The company is also developing ONCR-GBM program for treating brain cancer; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Biology Immunotherapy Cancers Cancer Immunotherapy Virotherapy Immunotherapies Therapies For Cancer Herpes Oncolytics Biotech Brain Cancer Herpes Simplex Herpes Simplex Virus Pelareorep Oncolytic Virus

Is ONCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.8603
52 Week Low 11.5
Average Volume 203,980
200-Day Moving Average 0.00
50-Day Moving Average 16.77
20-Day Moving Average 14.31
10-Day Moving Average 13.71
Average True Range 1.18
ADX 31.13
+DI 15.76
-DI 25.68
Chandelier Exit (Long, 3 ATRs ) 13.70
Chandelier Exit (Short, 3 ATRs ) 15.05
Upper Bollinger Band 16.93
Lower Bollinger Band 11.70
Percent B (%b) 0.33
BandWidth 36.52
MACD Line -0.85
MACD Signal Line -1.11
MACD Histogram 0.2523
Fundamentals Value
Market Cap 293.83 Million
Num Shares 21.8 Million
EPS
Price-to-Sales 0.00
Price-to-Book 17.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.88
Resistance 3 (R3) 14.99 14.62 14.64
Resistance 2 (R2) 14.62 14.25 14.56 14.56
Resistance 1 (R1) 14.03 14.03 13.85 13.93 14.48
Pivot Point 13.66 13.66 13.57 13.61 13.66
Support 1 (S1) 13.08 13.30 12.89 12.97 12.42
Support 2 (S2) 12.71 13.07 12.65 12.34
Support 3 (S3) 12.12 12.71 12.26
Support 4 (S4) 12.02